We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Israeli Researchers Want ImClone To Pay Royalties

Law360 (November 2, 2006, 12:00 AM EST) -- ImClone Systems Inc. should pay restitution and royalties and be required to get a license for its popular cancer drug Erbitux from the true inventors of the drug, an attorney for...
To view the full article, register now.